-
Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
in PRESS RELEASE 2021 onWomen in India are the first in the world to receive new…
00 -
-
Ferring presents new data at ESHRE 2021 supporting the use of Rekovelle® (follitropin delta) for individualized fertility treatment
in PRESS RELEASE 2021 onFerring presents new data at ESHRE 2021 supporting the use of Rekovelle®…
-
Ferring and Rebiotix Present Positive Interim Phase 3 Results from Open-Label Study of Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW)
in PRESS RELEASE 2021 onFerring and Rebiotix Present Positive Interim Phase 3 Results from Open-Label Study…
-
Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
in PRESS RELEASE 2021 onFerring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of…
-
Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW) 2021
in PRESS RELEASE 2021 onFerring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic…
-
-
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
in PRESS RELEASE 2021 onFerring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive…
PRESS RELEASE 2021
PRESS RELEASE 2021